Psychology Wiki

Genetic counseling: Neurofibromatosis - Type 2

34,203pages on
this wiki
Add New Page
Talk0 Share

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Clinical: Approaches · Group therapy · Techniques · Types of problem · Areas of specialism · Taxonomies · Therapeutic issues · Modes of delivery · Model translation project · Personal experiences ·

Neurofibromatosis - Type 2


  • How have things been since your last visit?
  • What questions or concerns would you like us to address today?


  • Disease characteristics
    • Genetic disorder that causes tumors to grow on various nerves
    • Also affects other tissues such as bones and skin
    • Two distinct types: NF-1 and NF-2
  • Inheritance
    • Autosomal dominant
    • Affected individuals have 50% chance of passing on mutation to each of their children
    • Half of affected individuals have de novo mutations
    • If neither parent has NF2, recurrence risk is very low - only one case of germline mosaicism reported
    • Uniform age of onset within families
  • Molecular genetics
    • Caused by mutation in the NF2 gene
    • Located at 22q12
    • Normal gene product is schwannomin or merlin
      • Homology to 4.1 family of cytoskeletal associated proteins
      • Has role in prevention of schwannoma formation
      • Tumor suppressor gene
  • Incidence is 1 in 40,000 people

Clinical Features and Natural HistoryEdit

  • Some variability in clinical manifestations
    • Variability within families is low
    • Suggests strong genotype-phenotype correlation
  • Average age of onset of symptoms is 18-24
    • Some people don't develop signs until their 40's or 50's
    • Considered adult-onset so may be underdiagnosed in children
    • Nonsense and frame shift mutations more severe
  • Bilateral vestibular schwannoma (acoustic neuroma)
    • Affect almost all patients with NF2
    • Tumor that arises from Schwann cells that support and protect nerves with insulation needed to conduct information on 8th cranial nerve
    • Initial symptoms include tinnitus (ringing in ears), hearing loss, and balance dysfunction
    • May result in hearing loss in one or both ears
  • Spinal tumors (>66%)
    • Include schwannomas that may cause numbness in part of body
    • Intramedullary tumors such as astrocytoma and ependymoma (5-33%)
    • Most individuals with spinal cord tumors have more than one
  • Meningiomas (50%)
    • Tumor that grows from cells that line the brain and spinal cord in protective sheets called meninges
    • May be intracranial or spinal
    • Cause different neurological symptoms depending on location
  • Ocular involvement (33%)
    • Cataracts
      • Known as juvenile posterior sublenticular opacity
      • May impair vision if not removed
    • Optic gliomas
      • Tumors on vision nerve
      • May lead to blindness
  • Other features
    • Other types of central nervous system tumors
    • Atypical café-au-lait spots
    • Cutaneous neurofibromas
  • Somatic mosaicism
    • Suspected in individuals with unilateral vestibular schwannoma and multiple other tumors on one side
    • More difficult to diagnose
  • Considerably shortened lifespan
    • Average age of death is 36 years
    • With improvements in diagnosis, monitoring, and surgery this is changing

Diagnosis/Testing OptionsEdit

  • Clinical diagnosis
    • Bilateral VIII nerve mass on CT or MRI (vestibular schwannomas)


    • First degree relative with NF2 and either
      • Unilateral 8th nerve mass


      • Two of the following
        • Meningioma
        • Glioma
        • Schwannoma
        • Juvenile posterior subcapsular lenticular opacity
  • Mutation analysis
    • Mutations identified in 65-80% of patients with clinical diagnosis
    • Testing provided by Athena Diagnostics/Mass Gen
    • Includes SSCP (single stranded conformational polymorphism)
    • May take up to 6 months for results
    • Costs about $2700
    • Considered appropriate to test unaffected at risk children and adults
  • Linkage analysis
    • Appropriate if more than one affected family member
    • Doesn't work for 50% of patients with de novo mutations
    • High accuracy because markers are very closely linked
  • Prenatal testing
    • Available for fetuses at 50% risk or greater
    • Can be performed if mutation identified in affected family member
    • Requires cells obtained from CVS or amniocentesis


  • Currently is no cure or treatment
  • Early recognition allows for earlier intervention and improved outcome
  • Begin screening in early teens
    • ABR and MRI exams for vestibular schwannomas
      • Surgery generally successfully preserves hearing is tumors small
      • Should begin learning sign language before hearing is lost
      • Hearing aids may help preserve hearing early on
    • Routine complete eye examinations
    • Routine neurological examinations
    • Intracranial, cranial nerve, and spinal tumors often slow growing

Differential DiagnosisEdit

  • NF1
    • Has Lisch nodules, axillary and inguinal freckling, and plexiform neurofibromas not seen in NF2
    • Patients with NF2 do not have mental retardation or learning problems
  • Unilateral vestibular schwannoma
    • Accounts for 5-10% of intracranial tumors
    • Less than 5% are bilateral and associated with NF-2
  • Schwannomatosis
    • Multiple schwannomas without vestibular schwannomas
    • Develop intracranial, spinal nerve root, or peripheral nerve tumors
  • Multiple meningiomas
    • Without vestibular schwannomas
    • Typically occur in older adults

Psychosocial IssuesEdit

  • Feelings of fear, anger, shock, denial over new diagnosis
  • Difficulty adjusting to loss of hearing
  • Burden of condition requiring extensive surveillance
  • Anxiety about possibility of shortened life span
  • Survivor guilt, transmitter guilt
  • Support system to help cope with diagnosis

Support ResourcesEdit

  • National Neurofibromatosis Foundation
95 Pine Street, 16th Floor
New York, NY 10005
Phone: 800-323-7938
  • Neurofibromatosis, Inc
8855 Annapolis Road, Suite 110
Lanham, MD 20706-2924
Phone: 410-461-5213
  • The Acoustic Neuroma Association
PO Box 12402
Atlanta, GA 30355
Phone: 404-237-2704


  • GeneReviews. "Neurofibromatosis 2" (2002).
  • "Neurofibromatosis Type 2: Information for Patients and Families." National Neurofibromatosis Foundation brochure.


The information in this outline was last updated in 2001.

This material has been imported fom the wikibook "Genetic counseling"[] under the GNU Free Documentation License.

Heckert GNU white Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation; with no Invariant Sections, no Front-Cover Texts, and no Back-Cover Texts. A copy of the license is included in the section entitled "GNU Free Documentation License."

Ad blocker interference detected!

Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers

Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.

Also on Fandom

Random Wiki